Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-02-25 @ 9:46 PM
Study NCT ID:
NCT04433156
Status:
UNKNOWN
Last Update Posted:
2023-05-18
First Post:
2020-06-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Sponsor:
Henan Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
HNSZLYYNHL03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None